510 related articles for article (PubMed ID: 23606729)
1. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
2. Cognitive complaints after breast cancer treatments: patient report and objective evidence.
Meyers CA
J Natl Cancer Inst; 2013 Jun; 105(11):761-2. PubMed ID: 23606730
[No Abstract] [Full Text] [Related]
3. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
4. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
7. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
8. Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.
Paquet L; Verma S; Collins B; Chinneck A; Bedard M; Song X
Psychooncology; 2018 Jan; 27(1):171-177. PubMed ID: 28129471
[TBL] [Abstract][Full Text] [Related]
9. Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.
Ganz PA; Petersen L; Castellon SA; Bower JE; Silverman DH; Cole SW; Irwin MR; Belin TR
J Clin Oncol; 2014 Nov; 32(31):3559-67. PubMed ID: 25267747
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and cognitive complaints in women with breast cancer.
Pullens MJ; De Vries J; Van Warmerdam LJ; Van De Wal MA; Roukema JA
Psychooncology; 2013 Aug; 22(8):1783-9. PubMed ID: 23109296
[TBL] [Abstract][Full Text] [Related]
11. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
[TBL] [Abstract][Full Text] [Related]
12. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
16. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study.
Naaktgeboren WR; Koevoets EW; Stuiver MM; van Harten WH; Aaronson NK; van der Wall E; Velthuis M; Sonke G; Schagen SB; Groen WG; May AM
Breast Cancer Res Treat; 2024 May; 205(1):75-86. PubMed ID: 38285111
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
18. Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood.
Veal BM; Scott SB; Jim HSL; Small BJ
Psychooncology; 2023 Aug; 32(8):1298-1305. PubMed ID: 37381150
[TBL] [Abstract][Full Text] [Related]
19. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
20. NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer.
Rick O; Reuß-Borst M; Dauelsberg T; Hass HG; König V; Caspari R; Götz-Keil G; Pfitzner J; Kerschgens C; Fliessbach K; Hoppe C
Psychooncology; 2018 Aug; 27(8):2016-2022. PubMed ID: 29771474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
